Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
---|
CEO | Mr. Matthew L. Trerotola |
IPO Date | May 8, 2008 |
Location | United States |
Headquarters | 2711 Centerville Road |
Employees | 6,550 |
Sector | Health Care |
Industries |
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Past 5 years
USD 143.55
USD 68.24
USD 214.54
USD 37.06
USD 166.69
USD 42.87
USD 42.43
USD 139.30
USD 354.31
USD 44.41
USD 12.80
USD 17.71
USD 97.38
USD 202.72
USD 41.24
StockViz Staff
January 15, 2025
Any question? Send us an email